Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma

Michaël H. Meel, Mark C. de Gooijer, Dennis S. Metselaar, A. Charlotte P. Sewing, Kenn Zwaan, Piotr Waranecki, Marjolein Breur, Levi C.M. Buil, Tonny Lagerweij, Laurine E. Wedekind, Jos W.R. Twisk, Jan Koster, Rintaro Hashizume, Eric H. Raabe, Ángel Montero Carcaboso, Marianna Bugiani, Timothy N. Phoenix, Olaf van Tellingen, Dannis G. van Vuurden, Gertjan J.L. Kaspers, Esther Hulleman

Open source

DOI
10.1158/1078-0432.ccr-19-3538
Published
2020-07-01
Container
Clinical Cancer Research
Publisher
American Association for Cancer Research (AACR)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-19-3538,
  title = {Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma},
  author = {Michaël H. Meel and Mark C. de Gooijer and Dennis S. Metselaar and A. Charlotte P. Sewing and Kenn Zwaan and Piotr Waranecki and Marjolein Breur and Levi C.M. Buil and Tonny Lagerweij and Laurine E. Wedekind and Jos W.R. Twisk and Jan Koster and Rintaro Hashizume and Eric H. Raabe and Ángel Montero Carcaboso and Marianna Bugiani and Timothy N. Phoenix and Olaf van Tellingen and Dannis G. van Vuurden and Gertjan J.L. Kaspers and Esther Hulleman},
  year = {2020},
  journal = {Clinical Cancer Research},
  doi = {10.1158/1078-0432.ccr-19-3538},
  url = {https://doi.org/10.1158/1078-0432.ccr-19-3538}
}

RIS

TY  - JOUR
TI  - Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma
AU  - Michaël H. Meel
AU  - Mark C. de Gooijer
AU  - Dennis S. Metselaar
AU  - A. Charlotte P. Sewing
AU  - Kenn Zwaan
AU  - Piotr Waranecki
AU  - Marjolein Breur
AU  - Levi C.M. Buil
AU  - Tonny Lagerweij
AU  - Laurine E. Wedekind
AU  - Jos W.R. Twisk
AU  - Jan Koster
AU  - Rintaro Hashizume
AU  - Eric H. Raabe
AU  - Ángel Montero Carcaboso
AU  - Marianna Bugiani
AU  - Timothy N. Phoenix
AU  - Olaf van Tellingen
AU  - Dannis G. van Vuurden
AU  - Gertjan J.L. Kaspers
AU  - Esther Hulleman
PY  - 2020
JO  - Clinical Cancer Research
DO  - 10.1158/1078-0432.ccr-19-3538
UR  - https://doi.org/10.1158/1078-0432.ccr-19-3538
ER  - 

APA

Meel, M. H., Gooijer, M. C. D., Metselaar, D. S., Sewing, A. C. P., Zwaan, K., Waranecki, P., Breur, M., Buil, L. C., Lagerweij, T., Wedekind, L. E., Twisk, J. W., Koster, J., Hashizume, R., Raabe, E. H., Carcaboso, Á. M., Bugiani, M., Phoenix, T. N., Tellingen, O. V., Vuurden, D. G. V., Kaspers, G. J., & Hulleman, E. (2020). Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-19-3538

Source records